Molecular Imaging: Page 90

FDG-PET changes treatment, staging for Merkel cell carcinoma

By Wayne Forrest

Australian researchers found that FDG-PET scans changed the management plan for more than one-third of patients with Merkel cell carcinoma and altered the disease stage in approximately one in five cases, according to a study in the August issue of the Journal of Nuclear Medicine.

August 14, 2013

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

August 11, 2013

How molecular techniques can transform abdominal oncology

By Philip Ward

Molecular imaging is enhancing assessment of therapy response and facilitating risk-adapted, personalized therapy in malignancies. Moreover, research on exploiting the specific molecular features of tumors can translate into better clinical care.

August 11, 2013

FDG-PET/CT tops biopsy in lymphoma patients

By AuntMinnieEurope.com staff writers

FDG-PET/CT achieved greater sensitivity, negative predictive value, and accuracy than bone marrow biopsy in patients with diffuse large B-cell lymphoma, according to a study published in the August issue of the Journal of Nuclear Medicine.

August 5, 2013

Positron signs supply deal with iThemba

By AuntMinnieEurope.com staff writers

PET vendor Positron has entered into a multiyear radioisotope supply agreement with iThemba Labs of Cape Town, South Africa.

July 30, 2013

Radiologists urged to play more prominent role in dementia

By Philip Ward

Radiologists must contribute more actively to an early diagnosis of cognitive decline that will help with the selection of at-risk patients for clinical trials and improve patient outcomes, top Swiss experts have stressed.

July 30, 2013

MRI in the face of economic adversity: Where next?

By Steve Holloway

MRI has been the flagship of diagnostic imaging since its conception in the mid-1970s. In 2012, demand for MRI equipment drove market revenues of 693 million euros in Europe, Middle East, and Africa annually. Yet with increasing cost pressure, is there a risk of stalling innovation?

July 28, 2013

FDG-PET, DWI-MRI help predict osteosarcoma chemo response

By Wayne Forrest

Combining FDG-PET/CT and diffusion-weighed MRI (DWI-MRI) may be useful for predicting the histologic response of osteosarcoma to neoadjuvant chemotherapy, according to a study published in the July issue of the Journal of Nuclear Medicine.

July 24, 2013

MRI method images glucose uptake in vivo

By Tami Freeman, PhD

Altered glucose metabolism is associated with a range of pathological conditions. In particular, solid tumors have more glucose consumption compared with healthy tissue -- a feature that can be used for tumor detection, monitoring disease progression, and evaluating therapy response, U.K. researchers found.

July 17, 2013

NaF-PET/CT beats scintigraphy, SPECT/CT for bone metastases

By Wayne Forrest

Sodium fluoride (NaF) PET/CT provides greater sensitivity and specificity for the detection of bone metastases than planar bone scintigraphy and SPECT/CT, according to a new pilot study from Copenhagen University Hospital.

July 7, 2013

Proton therapy shows promise in children

By Tami Freeman, PhD

Children are not just little adults, Dr. Anita Mahajan told attendees at the recent Particle Therapy Co-Operative Group meeting in Essen, Germany. Proton therapy is an ideal fit for children, but comes with unique challenges and constraints, she said.

July 3, 2013

Eckert & Ziegler to expand in Austria

By AuntMinnieEurope.com staff writers

Radiotherapy developer Eckert & Ziegler plans to expand its business in Austria by buying all shares of BSM Diagnostica Gesellschaft of Vienna, the company said.

June 25, 2013

Previous Page

Page 90 of 122

Next Page